Alembic receives USFDA final approval for Diltiazem Hydrochloride ER capsules
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
For Q2, Akums reported a consolidated total income of Rs. 1,046.6 crore
Q2 FY25 Total Income was at Rs. 85.4 crore
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Emcure Pharmaceuticals has reported total income of Rs. 2,037.63 crores during the period ended September 30, 2024
The company has reported total income of Rs. 1,693.15 crores during the period ended September 30, 2024
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
Neuland Laboratories has reported total income of Rs. 315.17 crores during the period ended September 30, 2024
The new range incorporates a product that also contains the S-PRG filler employed in the Giomer range
Subscribe To Our Newsletter & Stay Updated